A method comprising: hydrogenating an indole propionamide compound of
formula h with vitride, to form an aminopropyl indole compound of
formula i wherein m, Ar, R.sup.1 and R.sup.2 are as defined herein. The
compounds prepared by the method of the invention are useful as monoamine
reuptake inhibitors useful for treatment of CNS indications.